Health TrialsbyHealthPanel

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

This is a Multi-Center Study of IBI3026 in Participants With Locally Advanced, Unresectable or Metastatic Solid Tumors

This is a multicenter, open-label, phase I dose-escalation and expansion study of IBI3026 in participants with unresectable, locally advanced, or metastatic solid tumors. The study will be conducted in two phases: Phase 1 dose escalation and Phase 2 dose expansion. Safety will be monitored by the Safety Review Committee (SRC).

Participants needed: 300
Trial details
Phase: Early Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Innovent Biologics Technology Limited (Shanghai R&D Center)Updated: Feb 4, 2026Locations: 1
Eligibility criteria

Participants must have the ability to understand and sign a written informed con... [+7]

Prior treatment with IL-12 class cytokines or IL-12 inhibitors; [+7]

Read more
Status: Recruiting

A Study to Evaluate the Efficacy and Safety of IBI302inSubjects With nAMD

This study is designed for Open-label, multi-center, single-arm Phase II trail to evaluate the efficacy and safety of intravitreal injection of IBI302 in nAMD patients.

Participants needed: 800
Trial details
Phase: Phase 2Age: 50+Biological sex: AllType: InterventionalSponsor: Innovent Biologics Technology Limited (Shanghai R&D Center)Updated: Jan 8, 2026Locations: 1
Eligibility criteria

Have signed an informed consent form before participating in the research. [+3]

According to the investigator's judgment, concomitant ocular diseases/systemic d... [+9]

Read more